Patent details

Basic Information

Publication number:

EP3394103

PCT Application Number:

US2016068030

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP168265577

PCT Publication Number:

WO2017112775

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF ANTI-PD-1 ANTIBODIES AND BISPECIFIC ANTI-CD20/ANTI-CD3 ANTIBODIES TO TREAT CANCER

French Title of Invention:

COMBINAISON D'ANTICORPS ANTI-PD-1 ET D'ANTICORPS BISPÉCIFIQUES ANTI-CD20/ANTI-CD3 POUR TRAITER LE CANCER

German Title of Invention:

KOMBINATION AUS ANTI-PD-1-ANTIKÖRPERN UND BISPEZIFISCHEN ANTI-CD20/ANTI-CD3-ANTIKÖRPERN ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

21/12/2016

Grant date:

28/06/2023

EP Publication Date:

31/10/2018

PCT Publication Date:

29/06/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/06/2023

EP B1 Publication Date:

28/06/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

21/12/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/06/2023

 

 

Name:

Regeneron Pharmaceuticals, Inc.

Address:

777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

07/08/2023

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

THURSTON, Gavin

Address:

United States (US)

2

Name:

VARGHESE, Bindu

Address:

United States (US)

3

Name:

LOWY, Israel

Address:

United States (US)

4

Name:

BROWNSTEIN, Carrie

Address:

United States (US)

Priority

Priority Number:

201562270749 P

Priority Date:

22/12/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61P 35/02; C07K 16/28; A61P 35/00; A61K 39/00; A61K 45/06; C07K 16/30; A61K 39/395; A61P 43/00;

Publication

European Patent Bulletin

Issue number:

202326

Publication date:

28/06/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/12/2025

Annual Fee Number:

10

Annual Fee Amount:

131 Euro

Expected Payer:

Last Annual Fee Payment Date:

21/11/2024

Last Annual Fee Paid Number:

9

Last Annual Fee Paid Amount:

115 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
07/08/2023	Power Of Attorney	1
08/08/2023	Outgoing Correspondence	1